FDA Database Aims to Spark Orphan-Disease Drug Development


Published On: June 18th, 2010

The already-approved products in the Rare Disease Repurposing Database are unique in that they’ve also previously received orphan-drug designation.

Original post: 
FDA Database Aims to Spark Orphan-Disease Drug Development



Loading...


Comments are closed.